MarketCapTrends
SNOA
Sonoma Pharmaceuticals Inc. (SNOA)
NASDAQ · Healthcare

Sonoma Pharmaceuticals Inc. Shareholder Equity 2011–2025

Sonoma Pharmaceuticals Inc. annual/quarterly shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Sonoma Pharmaceuticals Inc. shareholder equity for the quarter ending March 31, 2025 were 4.4M, a 28.12% decrease year-over-year.
  • Sonoma Pharmaceuticals Inc. shareholder equity for 2025 were 4.4M, a 28.12% decrease from 2024.
  • Sonoma Pharmaceuticals Inc. shareholder equity for 2024 were 6.1M, a 23.07% decrease from 2023.
  • Sonoma Pharmaceuticals Inc. shareholder equity for 2023 were 8.0M, a 8.28% decrease from 2022.
  • Sonoma Pharmaceuticals Inc. shareholder equity for 2022 were 8.7M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Sonoma Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $)
2025$4
2024$6
2023$8
2022$9
2021$5
2020$6
2019$8
2018$15
2017$21
2016$10
2015$12
2014$12
2013$4
2012$-1
2011$2
Sonoma Pharmaceuticals Inc. Quarterly Shareholder Equity (Millions of US $)
2025-03-31$4
2024-03-31$6
2023-03-31$8
2022-03-31$9
2021-03-31$5
2020-03-31$6
2019-03-31$8
2018-03-31$15
2017-03-31$21
2016-03-31$10
2015-03-31$12
2014-03-31$12
2013-03-31$4
2012-03-31$-1
2011-03-31$2

Sonoma Pharmaceuticals Inc. Shareholder Equity — FAQ

Sonoma Pharmaceuticals Inc. (SNOA) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see SNOA's shareholder equity history?

The chart and table above show Sonoma Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.